Sir, We read with great interest the article by Gelfand et al. (2012) in the June issue of Brain. The authors described in detail vacuolar macular changes in the inner nuclear layer of patients with multiple sclerosis. This 'microcystic macular oedema' was associated with decreased visual acuity and a higher disability score. We found similar microcysts in the macular inner nuclear layer of a 13-year-old male suffering from neurofibromatosis type 1 and chronic compressive optic neuropathy in both eyes due to optic glioma (Fig. 1) . Since the incidental finding of the glioma 15 months ago, the bilateral microcystic macular inclusions remained unchanged and vision was stable at one line below normal in both eyes. Our observation raises the possibility that microcystic macular changes may be caused by optic nerve damage rather than by multiple sclerosis-specific processes. Not surprisingly Gelfand et al. (2012) found significantly reduced retinal nerve fibre layer thickness in their patients, supporting the view that optic neuropathy is a prerequisite for this phenomenon. The authors speculated that the macular cysts originate from breakdown of the blood-retinal barrier or from focal inflammation. The fact that our patient had chronic compressive optic neuropathy suggest that retrograde trans-synaptic degeneration (Syc et al., 2012) leads to cystic degeneration of the inner nuclear layer. In fact the phenotype of cystic cavitations in the inner nuclear layer has been described in enucleated human eyes with lesions of the optic nerve (Gills and Wadsworth, 1967) and in optic nerve crush experiments in non-human primates (VanBuren, 1963) . These reports showed histological evidence that retrograde trans-synaptic degeneration from optic neuropathy results in degeneration of the inner nuclear layer with formation of cystic spaces. On this basis the term microcystic macular oedema might be misleading and the term microcystic degeneration more appropriate. However, it remains to be clarified why only a fraction of patients with optic neuropathy display this phenotype while others do not.
If microcystic macular degeneration is a direct consequence of optic neuropathy, the suggestion of Gelfand et al. (2012) that microcystic macular changes might be of use as a marker in multiple sclerosis, should be reconsidered. The direct measurement of the causal reduction of retinal nerve fibre layer might represent a better option for this purpose. Nevertheless, this anatomically distinct and well defined macular alteration in some patients with optic neuropathy is intriguing and may lead to new insights into the pathophysiology of optic neuropathies. 
